157 related articles for article (PubMed ID: 36089905)
1. Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of
Abbas HA; Ayoub E; Sun H; Kanagal-Shamanna R; Short NJ; Issa G; Yilmaz M; Pierce S; Rivera D; Cham B; Wing S; Li Z; Hammond D; Jabbour E; Borthakur G; Garcia-Manero G; Andreeff M; Daver N; Kadia T; Konopleva M; DiNardo C; Ravandi F
Leuk Lymphoma; 2022 Dec; 63(13):3105-3116. PubMed ID: 36089905
[TBL] [Abstract][Full Text] [Related]
2. Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).
Zhang R; Kim YM; Wang X; Li Y; Lu X; Sternenberger AR; Li S; Lee JY
Int J Med Sci; 2015; 12(9):719-26. PubMed ID: 26392809
[TBL] [Abstract][Full Text] [Related]
3. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
Hosono N
Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
[TBL] [Abstract][Full Text] [Related]
4. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
[TBL] [Abstract][Full Text] [Related]
5. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.
Hasle H; Alonzo TA; Auvrignon A; Behar C; Chang M; Creutzig U; Fischer A; Forestier E; Fynn A; Haas OA; Harbott J; Harrison CJ; Heerema NA; van den Heuvel-Eibrink MM; Kaspers GJ; Locatelli F; Noellke P; Polychronopoulou S; Ravindranath Y; Razzouk B; Reinhardt D; Savva NN; Stark B; Suciu S; Tsukimoto I; Webb DK; Wojcik D; Woods WG; Zimmermann M; Niemeyer CM; Raimondi SC
Blood; 2007 Jun; 109(11):4641-7. PubMed ID: 17299091
[TBL] [Abstract][Full Text] [Related]
6. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
El-Menoufy MAM; Mourad ZI; Farahat NM
J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
[TBL] [Abstract][Full Text] [Related]
8. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM
Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
[TBL] [Abstract][Full Text] [Related]
9. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
11. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of
Liu H; Shi Y; Tao S; Li Y; Wang C; Yu L
Hematology; 2023 Dec; 28(1):2223866. PubMed ID: 37313982
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P
Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899
[TBL] [Abstract][Full Text] [Related]
15. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.
Poiré X; Labopin M; Polge E; Volin L; Finke J; Ganser A; Blaise D; Yakoub-Agha I; Beelen D; Forcade E; Lioure B; Socié G; Niederwieser D; Labussière-Wallet H; Maertens J; Cornelissen J; Craddock C; Mohty M; Esteve J; Nagler A
Am J Hematol; 2020 Mar; 95(3):282-294. PubMed ID: 31876307
[TBL] [Abstract][Full Text] [Related]
16. Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis.
Pitel BA; Sharma N; Zepeda-Mendoza C; Smadbeck JB; Pearce KE; Cook JM; Vasmatzis G; Sachs Z; Kanagal-Shamanna R; Viswanatha D; Xiao S; Jenkins RB; Xu X; Hoppman NL; Ketterling RP; Peterson JF; Greipp PT; Baughn LB
Blood Cancer J; 2021 Feb; 11(2):18. PubMed ID: 33563889
[No Abstract] [Full Text] [Related]
17. The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q).
McNerney ME; Brown CD; Peterson AL; Banerjee M; Larson RA; Anastasi J; Le Beau MM; White KP
Br J Haematol; 2014 Aug; 166(4):550-6. PubMed ID: 24931631
[TBL] [Abstract][Full Text] [Related]
18. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Becker H; Pfeifer D; Ihorst G; Pantic M; Wehrle J; Rüter BH; Bullinger L; Hackanson B; Germing U; Kuendgen A; Platzbecker U; Döhner K; Ganser A; Hagemeijer A; Wijermans PW; Döhner H; Duyster J; Lübbert M
Ann Hematol; 2020 Jul; 99(7):1551-1560. PubMed ID: 32504186
[TBL] [Abstract][Full Text] [Related]
19. Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
Herry A; Douet-Guilbert N; Guéganic N; Morel F; Le Bris MJ; Berthou C; De Braekeleer M
Ann Hematol; 2006 Apr; 85(4):244-9. PubMed ID: 16425025
[TBL] [Abstract][Full Text] [Related]
20. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
